We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Parallel Tracking i-biomarkerT Development with Drug Development for Maximum Benefit

Video   Jul 07, 2015

 

Molecular imaging is increasingly being used to support decision-making in early-stage drug development, particularly in the CNS. Providing invaluable information on the so-called ‘three pillars of drug survival’, namely tissue delivery, target engagement and pharmacological effect, it can be seen as a kind of precision pharmacology However, a lack of appreciation of when and how to use imaging and a lack of suitable tools means imaging is often an afterthought and employed in a post-mortem of drug failure. Timely development of imaging biomarkers will ensure the full translational value of this technology can be realised 

 
 
 
 

Recommended Videos

Scar Wars: Repairing the Liver

Video

This animation explores several of the latest therapeutic approaches that aim to tap into this self-healing capacity.

WATCH NOW

Cas13: Cas9's Cool Detective Cousin

Video

This animation depicts how Cas13—a CRISPR-associated protein—may be adapted to detect human disease. This new diagnostic tool, called SHERLOCK, targets RNA (rather than DNA), and has the potential to transform research and global public health.

WATCH NOW

Bacterial DNA Jiggling Motion Halted Before Cell Death

Video

Watch how the jiggling motion of bacterial DNA stops when a natural antimicrobial peptide permeates the E. coli membrane. This novel mechanism helps explain why bacteria develop resistance very slowly and may inform the design of new antimicrobial agents.

WATCH NOW

 

Like what you just watched? You can find similar content on the communities below.

Analysis & Separations Diagnostics Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE